| Record ID | marc_records_scriblio_net/part24.dat:145948735:1246 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part24.dat:145948735:1246?format=raw |
LEADER: 01246nam 2200337 a 4500
001 94190812
003 DLC
005 19990716000000.0
008 940706s1994 dcua b f000 0 eng c
010 $a 94190812
040 $aDGPO/DLC$cOCO$dDLC
043 $an-us---
050 04 $aHD9666.6$b.C57 1994
074 $a1005-C
086 0 $aY 10.2:H 34/7
100 1 $aCook, Anna.
245 10 $aHow health care reform affects pharmaceutical research and development /$cthe Congress of the United States, Congressional Budget Office.
260 $aWashington, D.C. :$bThe Office,$c[1994]
300 $axv, 64 p. :$bill. ;$c28 cm.
440 0 $aCBO study
500 $a"Anna Cook and Philip Webre ... wrote the study"--Pref.
500 $aShipping list no.: 94-0218-P.
500 $a"June 1994"--Cover.
504 $aIncludes bibliographical references.
650 0 $aPharmaceutical industry$zUnited States.
650 0 $aDrugs$xResearch$zUnited States.
650 0 $aInsurance, Pharmaceutical services$xGovernment policy$zUnited States.
650 0 $aPrescription pricing$xGovernment policy$zUnited States.
650 0 $aHealth care reform$zUnited States.
700 1 $aWebre, Philip.
710 1 $aUnited States.$bCongressional Budget Office.